Cargando…

Toward a human-centered use of technology: a stakeholder analysis of harm reduction and CBO staff

BACKGROUND: Technology can enable syringe service programs (SSPs) and other community-based organizations (CBOs) operating under a harm reduction framework to work with an increased number of clients and can also enable organizations to offer services more effectively (e.g., offering HIV testing in...

Descripción completa

Detalles Bibliográficos
Autores principales: Aronson, Ian David, Bennett, Alex S., Freeman, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570409/
https://www.ncbi.nlm.nih.gov/pubmed/33076911
http://dx.doi.org/10.1186/s12954-020-00422-y
_version_ 1783596942284029952
author Aronson, Ian David
Bennett, Alex S.
Freeman, Robert
author_facet Aronson, Ian David
Bennett, Alex S.
Freeman, Robert
author_sort Aronson, Ian David
collection PubMed
description BACKGROUND: Technology can enable syringe service programs (SSPs) and other community-based organizations (CBOs) operating under a harm reduction framework to work with an increased number of clients and can also enable organizations to offer services more effectively (e.g., offering HIV testing in ways participants may be more likely to accept). In the current time of COVID-19 social distancing, technology can also help organizations more safely provide services to people with compromised immune systems and to clients who might otherwise not be reached. However, technology projects implemented in harm reduction settings are frequently conceptualized and developed by researchers or technology specialists rather than by SSP staff or clients. METHODS: To more effectively meet the needs of SSPs and other CBOs across the USA, our team conducted qualitative interviews with 16 individuals who have extensive backgrounds working in the field of harm reduction. Interviews were digitally recorded and professionally transcribed, and the transcripts were checked for accuracy by the interviewers. The resulting transcripts were coded and analyzed to determine emerging themes. RESULTS: Interviewees mentioned the ability of technology to deliver consistent quality messaging to multiple clients at the same time and the potential to customize or tailor technology-based messaging to specific client populations as positive benefits. Clear barriers to technology use also emerged, in particular regarding privacy, data security, and the need to maintain client trust when discussing sensitive issues (e.g., illicit drug use). CONCLUSIONS: Technology offers the potential to deliver consistently high-quality health communication and maintain contact with clients who may have no other access to care. If designed and managed effectively, technology can also address issues related to providing services during times when physical contact is limited due to COVID-19 social distancing measures.
format Online
Article
Text
id pubmed-7570409
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75704092020-10-20 Toward a human-centered use of technology: a stakeholder analysis of harm reduction and CBO staff Aronson, Ian David Bennett, Alex S. Freeman, Robert Harm Reduct J Research BACKGROUND: Technology can enable syringe service programs (SSPs) and other community-based organizations (CBOs) operating under a harm reduction framework to work with an increased number of clients and can also enable organizations to offer services more effectively (e.g., offering HIV testing in ways participants may be more likely to accept). In the current time of COVID-19 social distancing, technology can also help organizations more safely provide services to people with compromised immune systems and to clients who might otherwise not be reached. However, technology projects implemented in harm reduction settings are frequently conceptualized and developed by researchers or technology specialists rather than by SSP staff or clients. METHODS: To more effectively meet the needs of SSPs and other CBOs across the USA, our team conducted qualitative interviews with 16 individuals who have extensive backgrounds working in the field of harm reduction. Interviews were digitally recorded and professionally transcribed, and the transcripts were checked for accuracy by the interviewers. The resulting transcripts were coded and analyzed to determine emerging themes. RESULTS: Interviewees mentioned the ability of technology to deliver consistent quality messaging to multiple clients at the same time and the potential to customize or tailor technology-based messaging to specific client populations as positive benefits. Clear barriers to technology use also emerged, in particular regarding privacy, data security, and the need to maintain client trust when discussing sensitive issues (e.g., illicit drug use). CONCLUSIONS: Technology offers the potential to deliver consistently high-quality health communication and maintain contact with clients who may have no other access to care. If designed and managed effectively, technology can also address issues related to providing services during times when physical contact is limited due to COVID-19 social distancing measures. BioMed Central 2020-10-19 /pmc/articles/PMC7570409/ /pubmed/33076911 http://dx.doi.org/10.1186/s12954-020-00422-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Aronson, Ian David
Bennett, Alex S.
Freeman, Robert
Toward a human-centered use of technology: a stakeholder analysis of harm reduction and CBO staff
title Toward a human-centered use of technology: a stakeholder analysis of harm reduction and CBO staff
title_full Toward a human-centered use of technology: a stakeholder analysis of harm reduction and CBO staff
title_fullStr Toward a human-centered use of technology: a stakeholder analysis of harm reduction and CBO staff
title_full_unstemmed Toward a human-centered use of technology: a stakeholder analysis of harm reduction and CBO staff
title_short Toward a human-centered use of technology: a stakeholder analysis of harm reduction and CBO staff
title_sort toward a human-centered use of technology: a stakeholder analysis of harm reduction and cbo staff
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570409/
https://www.ncbi.nlm.nih.gov/pubmed/33076911
http://dx.doi.org/10.1186/s12954-020-00422-y
work_keys_str_mv AT aronsoniandavid towardahumancentereduseoftechnologyastakeholderanalysisofharmreductionandcbostaff
AT bennettalexs towardahumancentereduseoftechnologyastakeholderanalysisofharmreductionandcbostaff
AT freemanrobert towardahumancentereduseoftechnologyastakeholderanalysisofharmreductionandcbostaff